DiscoverPeerPOV: The Pulse on MedicineHER2+ Horizons: Episode 2: Sequencing After Progression—What Comes Next?
HER2+ Horizons: Episode 2: Sequencing After Progression—What Comes Next?

HER2+ Horizons: Episode 2: Sequencing After Progression—What Comes Next?

Update: 2025-09-24
Share

Description

In this episode, Sara Tolaney, MD, of Dana-Farber Cancer Institute, discusses sequencing strategies after progression in HER2-positive metastatic breast cancer. She reviews current second-line standards, considerations for patients with brain metastases, and emerging therapies in the post–T-DXd setting.
Let us know what you thought of this week’s episode on Twitter: @physicianswkly
Want to share your medical expertise, research, or unique experience in medicine on the PW podcast? Email us at editorial@physweekly.com!
Thanks for listening!
Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

HER2+ Horizons: Episode 2: Sequencing After Progression—What Comes Next?

HER2+ Horizons: Episode 2: Sequencing After Progression—What Comes Next?

Physician's Weekly